| Financial Year |
March 31 2023 |
| Monetary Funds |
428,036,011.56 |
| Held-for-trading Financial Assets |
20,045,888.89 |
| Notes Receivable |
1,069,296.25 |
| Accounts Receivable |
242,190,275.49 |
| Advances to Suppliers |
34,903,233.12 |
| Other Receivables |
17,321,887.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
534,522,006.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,142,523.90 |
| Total Current Assets |
1,483,724,395.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,521,217.36 |
| Fixed Assetes |
945,956,493.56 |
| Under-construction Projects |
107,284,113.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
126,668,453.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,060,580.42 |
| Deferred Income Tax Assets |
23,572,378.03 |
| Other Non-Current Assets |
88,674,559.32 |
| Sub-Total of Non-Current Assets |
1,326,682,484.78 |
| Total Assets |
2,810,406,879.84 |
| Short-Term Loans |
169,799,191.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
349,499,993.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,691,902.47 |
| Taxes Payable |
16,480,256.99 |
| Interest Payable |
-- |
| Dividend Payable |
2,785,873.88 |
| Other payables |
135,706,660.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
672,820.01 |
| Other Current Liabilities |
13,725,361.00 |
| Sub-Total of Current Liabilities |
754,195,155.36 |
| Long-term Loans |
95,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,754,936.76 |
| Deferred Income Tax Liabilities |
4,568,893.60 |
| Other Non-Current Liabilities |
4,447,885.94 |
| Sub-Total of Non-Current Liabilities |
125,868,458.87 |
| Total Liabilities |
880,063,614.23 |
| Paid-In Capital(Or Share Stock) |
293,236,600.00 |
| Capital Surplus |
36,561,505.07 |
| Surplus Reserve |
274,651,923.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,120,838,247.54 |
| Minority Stockholder's Interest |
200,221,218.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,730,122,046.96 |
| Owner's Equity（Stockholder's Equity） |
1,930,343,265.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,810,406,879.84 |
